Heritage Trust Co Acquires Shares of 1,757 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Heritage Trust Co bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,757 shares of the medical equipment provider's stock, valued at approximately $917,000.

Other large investors have also recently made changes to their positions in the company. Atala Financial Inc purchased a new position in Intuitive Surgical during the 4th quarter valued at about $25,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth $28,000. Hurley Capital LLC bought a new position in Intuitive Surgical in the fourth quarter worth about $28,000. Finally, Summit Securities Group LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. UBS Group increased their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Piper Sandler reiterated an "overweight" rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a "buy" rating in a report on Monday. Finally, Robert W. Baird reduced their price target on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a report on Tuesday, March 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $611.81.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company's stock, valued at $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $4.41 during mid-day trading on Thursday, hitting $485.75. The company's stock had a trading volume of 883,047 shares, compared to its average volume of 1,599,180. The company has a market cap of $173.01 billion, a PE ratio of 75.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm's 50 day moving average is $526.67 and its 200 day moving average is $532.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.